Global Lateral Flow Immunoassays Market By Type (Kits & Reagents, Lateral?Flow?Readers, Digital/Mobile Readers, and Benchtop Readers), By Application (Hospitals and Clinics, Diagnostic Laboratories, Home Care, and Pharmaceutical and Biotechnology Companies), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 139194
- 18-Dec
- PDF/PPT/Word
-
Report Details
Global Lateral Flow Immunoassays Market is estimated to be valued US$ XX.X million in 2019. The report on Lateral Flow Immunoassays Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global lateral flow immunoassays market is segmented on the basis of Type, Application, and geography.
In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.
Lateral Flow Immunoassays Market Scope:
By type, the market is segmented into Kits & Reagents, Lateral Flow Readers, Digital/Mobile Readers, and Benchtop Readers. By Application, the market is divided into Hospitals and Clinics, Diagnostic Laboratories, Home Care, and Pharmaceutical and Biotechnology Companies.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche AG, Danaher Corporation, Siemens AG, Becton, Dickinson and Company, bioM rieux SA, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., PerkinElmer Inc., Hologic Inc., Quidel Corporation, and Merck KgaA.Key Market Segments
Type
Kits & Reagents
Lateral Flow Readers
Digital/Mobile Readers
Benchtop Readers
Application
Hospitals and Clinics
Diagnostic Laboratories
Home Care
Pharmaceutical and Biotechnology Companies
Key Market Players included in the report:
Abbott Laboratories
F. Hoffmann-La Roche AG
Danaher Corporation
Siemens AG
Becton
Dickinson and Company
bioM rieux SA
Bio-Rad Laboratories Inc.
Thermo Fisher Scientific Inc.
QIAGEN N.V.
PerkinElmer Inc.
Hologic Inc.
Quidel Corporation
Merck KgaA
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Lateral Flow Immunoassays Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Lateral Flow Immunoassays Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Lateral Flow Immunoassays Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Lateral Flow Immunoassays Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Lateral Flow Immunoassays Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Lateral Flow Immunoassays Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Lateral Flow Immunoassays sub-markets, depending on key regions (various vital states).
To analyze Lateral Flow Immunoassays Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Lateral Flow Immunoassays Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
Primary worldwide Lateral Flow Immunoassays Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Lateral Flow Immunoassays Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary
2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Lateral Flow Immunoassays Market Overview
3.1. Lateral Flow Immunoassays Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy4. Global Lateral Flow Immunoassays Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
4.1. Global Lateral Flow Immunoassays Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Kits & Reagents4.4. Lateral?Flow?Readers
4.5. Digital/Mobile Readers
4.6. Benchtop Readers
5. Global Lateral Flow Immunoassays Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Lateral Flow Immunoassays Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Hospitals and Clinics5.4. Diagnostic Laboratories
5.5. Home Care
5.6. Pharmaceutical and Biotechnology Companies
6. Global Lateral Flow Immunoassays Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Lateral Flow Immunoassays Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Lateral Flow Immunoassays Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Lateral Flow Immunoassays Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific6.4. Latin America
6.4.1. Latin America Lateral Flow Immunoassays Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Lateral Flow Immunoassays Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA7. Global Lateral Flow Immunoassays Market Competitive Landscape, Market Share Analysis, and Company Profiles
7.1. Market Share Analysis
7.2. Company Profiles
7.3. Abbott Laboratories7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. F. Hoffmann-La Roche AG
7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. Danaher Corporation
7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Siemens AG
7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Becton
7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. Dickinson and Company
7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. bioM?rieux SA
7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. Bio-Rad Laboratories#Inc.
7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. Thermo Fisher Scientific Inc.
7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments7.12. QIAGEN N.V.
7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments7.13. PerkinElmer Inc.
7.13.1. Company Overview
7.13.2. Financial Highlights
7.13.3. Product Portfolio
7.13.4. SWOT Analysis
7.13.5. Key Strategies and Developments7.14. Hologic Inc.
7.14.1. Company Overview
7.14.2. Financial Highlights
7.14.3. Product Portfolio
7.14.4. SWOT Analysis
7.14.5. Key Strategies and Developments7.15. Quidel Corporation
7.15.1. Company Overview
7.15.2. Financial Highlights
7.15.3. Product Portfolio
7.15.4. SWOT Analysis
7.15.5. Key Strategies and Developments7.16. Merck KgaA
7.16.1. Company Overview
7.16.2. Financial Highlights
7.16.3. Product Portfolio
7.16.4. SWOT Analysis
7.16.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
